logo
Menu

NGS-BRICS Project: BRICS Cooperation in Biotechnology and Biomedicine

Published on Feb 12, 2026 02:21 PM - Modified 3 months ago
NGS-BRICS Project: BRICS Cooperation in Biotechnology and Biomedicine

NGS-BRICS Project: BRICS Cooperation in Biotechnology and Biomedicine

The NGS-BRICS project formed a five-country consortium to integrate national genome research and develop innovative solutions to address the COVID-19 pandemic. Core objectives included sharing SARS-CoV-2 genomic knowledge across BRICS countries, tracking virus spread, identifying precise pandemic emergence patterns, developing diagnostic and therapeutic approaches based on genome sequencing, and strengthening national capacities for COVID-19 genomic data production and analysis.

Throughout the project, scientists collaborated online and exchanged real-time data, significantly improving surveillance approaches during the pandemic and enhancing human resource capacity across BRICS member states.

Call Number BRICS STI Framework Programme Call in Response to COVID-19 Pandemic, 2020
Project Code and Acronym BRICS2020-049 “NGS-BRICS”
Country Research Institutions Principal Investigators
🇧🇷 Brazil
National Laboratory for Scientific Computation (LNCC/MCTI) Ana Tereza Ribeiro de Vasconcelos
🇷🇺 Russia
Skolkovo Institute of Science and Technology Georgii Bazykin
🇮🇳 India
National Institute of Biomedical Genomics Arindam Maitra
🇨🇳 China
Beijing Institute of Genomics, CAS Mingkun Li
🇿🇦 South Africa
University of KwaZulu-Natal Tulio de Oliveira
Funding Agencies National Council for Scientific and Technological Development of Brazil (CNPq), Russian Center for Scientific Information (RCSI), Department of Biotechnology of India (DBT), Department of Science and Technology of India (DST), National Natural Science Foundation of China (NSFC), South African Medical Research Council (SAMRC)